Bakrie & Brothers Tbk PT
OTC:PKBAF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bakrie & Brothers Tbk PT
OTC:PKBAF
|
ID |
|
Aptose Biosciences Inc
TSX:APS
|
CA |
|
A
|
Arcosa Inc
F:EOB
|
US |
|
Havas NV
F:JP71
|
FR |
|
Delek Logistics Partners LP
NYSE:DKL
|
US |
|
Pieris Pharmaceuticals Inc
F:PI6
|
US |
|
U
|
UltraGreen.ai Ltd
SGX:ULG
|
SG |
|
G
|
General Electric Co
DUS:GCP
|
US |
|
P
|
Precigen Inc
SWB:I5X
|
US |
|
Medx Health Corp
XTSX:MDX
|
CA |
|
R
|
Radian Group Inc
XBER:RAG
|
US |
|
H
|
Hollysys Automation Technologies Ltd
F:46H
|
CN |
|
Phunware Inc
F:2RJA
|
US |
Shareholder Yield
Current shareholder yield for 
PKBAF is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
PKBAF Price
Bakrie & Brothers Tbk PT
| Average Annual Return | 56.25% |
| Standard Deviation of Annual Returns | 166.3% |
| Max Drawdown | -98% |
| Market Capitalization | 29.4T USD |
| Shares Outstanding | 173 416 830 000 |
| Percentage of Shares Shorted |
N/A
|
